New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 7, 2022 - Teva launched an AB-rated generic version of Bristol-Myers Squibb’s (BMS) Revlimid (lenalidomide) 5 mg, 10 mg, 15 mg and 25 mg capsules.
Download PDF
Return to publications
